Filing Details
- Accession Number:
- 0001209191-17-055830
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-04 16:22:26
- Reporting Period:
- 2017-10-02
- Accepted Time:
- 2017-10-04 16:22:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001233 | Sangamo Therapeutics Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1691262 | Iii A. Curt Herberts | C/O Sangamo Therapeutics, Inc. Point Richmond Tech Ctr, 501 Canal Blvd. Richmond CA 94804 | Sr.vp & Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-02 | 5,830 | $5.41 | 21,663 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-02 | 5,830 | $15.00 | 15,833 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-10-02 | 5,416 | $8.87 | 21,249 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-02 | 5,416 | $15.00 | 15,833 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-10-02 | 3,754 | $9.41 | 19,587 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-02 | 3,754 | $16.00 | 15,833 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-02 | 5,830 | $0.00 | 5,830 | $5.41 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-02 | 5,416 | $0.00 | 5,416 | $8.87 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-02 | 3,754 | $0.00 | 3,754 | $9.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-12-05 | No | 4 | M | Direct | |
| 4,584 | 2025-07-26 | No | 4 | M | Direct | |
| 33,746 | 2025-12-07 | No | 4 | M | Direct |
Footnotes
- All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- The shares underlying the stock option are fully vested and exercisable.
- One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the July 27, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
- One-quarter (1/4) of the option shares will vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
Billionaire Hedge Funds
